Maquet Cardiovascular LLC
USPTO PatentsView assignee record - 68 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Maquet ranks #5,093 of 49,997 tracked US assignees by granted-patent volume, with 68 patents across 15 technology areas.
- #5,093
- of 49,997 US assignees by volume
- Top 23%
- by Innovation Score (45.7/100)
- 23.4
- avg claims per patent
- -60%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5093 · US Corporation #5,093 · 68 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 68 grants
- UPPER-Q #5,093/49,997
- PHOTO-FINISH Kellogg
- CPC-FOCUS A61B · 15 areas
- INNOV-PAR 45.7/100
- CLAIMS-DENSE 23.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -60% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Kellogg Company (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Maquet’s 45.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Maquet
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- CrowdComfort · near
CrowdComfort · near
46 score
- Eagle Aerospace · near
Eagle Aerospace · near
46 score
- Maquet Cardiovascular · this assignee
Maquet Cardiovascular · this assignee
46 score
- Nisshin Steel · near
Nisshin Steel · near
46 score
- Hangzhou Great Star… · near
Hangzhou Great Star… · near
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Maquet's Innovation Score is 45.7/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Maquet?
Each dot is one of Maquet’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Maquet’s own 23.4 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Maquet's grants concentrate
Maquet Cardiovascular LLC is a focused PatentsView assignee: 15 CPC subclasses with 61.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (14 grants) versus a trough of 2 in 2023. By volume, Maquet sits between Kellogg Company and Middle Chart, LLC.
Maquet's three-year grant acceleration
From 2019–2021 to 2022–2024, Maquet Cardiovascular LLC moved from 22 to 11 grants (0.50x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Maquet's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kellogg
Kellogg Company
68 patents
- Komori
Komori Corporation
68 patents
- Kumu Networks
Kumu Networks, Inc.
68 patents
- Lvmh Recherche
Lvmh Recherche
68 patents
- Medizinische Hoch…
Medizinische Hochschule Hannover
68 patents
- Medtronic Holding…
Medtronic Holding Company Sarl
68 patents
- Merz Pharma & Kgaa
Merz Pharma GmbH & Co. KGaA
68 patents
- Middle Chart
Middle Chart, LLC
68 patents
- Maquet Cardiovasc… ◀
Maquet Cardiovascular LLC
68 patents
What this shows Maquet holds 68 patents at rank #5,091, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Maquet
By rank, the assignees closest to #5,091 in granted patent volume.
- Kellogg Company #5,087 · 68 patents
- Komori Corporation #5,088 · 68 patents
- Kumu Networks, Inc. #5,089 · 68 patents
- Lvmh Recherche #5,090 · 68 patents
- Medizinische Hochschule Hannover #5,092 · 68 patents
- Medtronic Holding Company Sarl #5,093 · 68 patents
- Merz Pharma GmbH & Co. KGaA #5,094 · 68 patents
- Middle Chart, LLC #5,095 · 68 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Maquet's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Maquet, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Maquet ranks #452 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (46 here).
Similar claim depth
Nearest assignees by average claims per patent (23.4 here).
Maquet's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 23% higher than 77% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 7.4% |
| 2016 | 8 | 11.8% |
| 2017 | 14 | 20.6% |
| 2018 | 6 | 8.8% |
| 2019 | 14 | 20.6% |
| 2020 | 3 | 4.4% |
| 2021 | 5 | 7.4% |
| 2022 | 7 | 10.3% |
| 2023 | 2 | 2.9% |
| 2024 | 2 | 2.9% |
| 2025partial year | 2 | 2.9% |
Which technologies does Maquet Cardiovascular LLC patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Maquet Cardiovascular LLC's patent record in context - here's where to go next.
- Maquet Cardiovascular LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 61.8% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #5,093 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Maquet Cardiovascular LLC against Kellogg Company, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.